I-MAB (IMAB)
1.76
-0.01
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
I-MAB Debt to Equity Ratio: 0.0517 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0517 |
| June 30, 2023 | 0.0122 |
| December 31, 2022 | 0.0065 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| June 30, 2020 | 0.0406 |
| June 30, 2019 | -0.0807 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0807
Minimum
Jun 2019
0.0517
Maximum
Dec 2023
0.0038
Average
0.0032
Median
Debt to Equity Ratio Benchmarks
| Summit Therapeutics Inc | -- |
| Verastem Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 368.62M |
| Total Liabilities (Quarterly) | 126.23M |
| Shareholders Equity (Quarterly) | 242.38M |
| Current Ratio | 5.674 |
| Net Debt Paydown Yield | -2.73% |